Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes

Stopped early · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

The main purpose of the study is to assess the feasibility and acceptability of a Culturally-Tailored Cognitive Behavior intervention (CT-CB) for African American patients with uncontrolled Type 2 diabetes. After the baseline visit subjects will be randomly assigned to undergo a six session group-based or web-based behavioral intervention (CT-CB) program or to general education (usual care). The intervention duration is 12 weeks.

Key facts

Study ID

NCT03562767

Run by

Emory University

People needed

20

Starts

2018-12-05

Expected to finish

2019-05-30

Last updated by the study team

2023-08-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age: 18 years or older
• Fluency in English
• African American
• HbA1C>8%

You may not qualify if…

• Subjects with no web access,
• Subjects using an insulin pump,
• Subjects that are pregnant
• Subjects that have active substance abuse including alcohol,
• Subjects with visual impairment or have severe hearing or other physical disabilities that would be a barrier for participating in-group or web sessions

Where it is running

• Emory Dunwoody Clinic — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.